Overview
To confirm the safety of tolvaptan sodium phosphate in patients with volume overload in heart failure.
Eligibility
Inclusion Criteria:
-
Exclusion Criteria:
- patients with a known hypersensitivity to Tolvaptan sodium phosphate or Tolvaptan
To confirm the safety of tolvaptan sodium phosphate in patients with volume overload in heart failure.
Inclusion Criteria:
-
Exclusion Criteria:
NCT05712746
Otsuka Pharmaceutical Co., Ltd.
26 January 2024
Congrats! You have your own personal workspace now.